A summary of research written by Vibeke Strand, MD, clinical professor in division of immunology/rheumatology at Stanford ...

Number 3: Part 2 of our series diving into the Association for Accessible Medicines' (AAM) latest report discusses that while ...

Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...

Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $24.58, a high ...

The following is a summary of “Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review,” published in the September 2024 issue of ...

The 2024 honorees for the President’s Award for Excellence in Teaching represent each school, the College of Arts and ...

The Food and Drug Administration, as expected, approved KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage is milder side effects.

Healthy adults who contracted COVID-19 had subtle but measurable declines in memory and cognitive performance lasting up to a ...

In the latest quarter, 9 analysts provided ratings for Medpace Hldgs MEDP, showcasing a mix of bullish and bearish ...

Eli Lilly will invest $4.5 billion to create the Lilly Medicine Foundry, which the drug giant says will be the first-ever ...